nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—SLC6A3—Parkinson's disease	0.184	0.244	CbGaD
Trimipramine—HTR1A—Parkinson's disease	0.161	0.214	CbGaD
Trimipramine—DRD2—Parkinson's disease	0.137	0.182	CbGaD
Trimipramine—HTR2A—Parkinson's disease	0.106	0.14	CbGaD
Trimipramine—CYP2D6—Parkinson's disease	0.0967	0.128	CbGaD
Trimipramine—ABCB1—Parkinson's disease	0.0691	0.0916	CbGaD
Trimipramine—HTR3A—enteric nervous system—Parkinson's disease	0.00863	0.0867	CbGeAlD
Trimipramine—HTR3A—myenteric nerve plexus—Parkinson's disease	0.00654	0.0657	CbGeAlD
Trimipramine—SLC6A2—locus ceruleus—Parkinson's disease	0.00382	0.0384	CbGeAlD
Trimipramine—HTR2A—enteric nervous system—Parkinson's disease	0.00348	0.035	CbGeAlD
Trimipramine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00302	0.0304	CbGeAlD
Trimipramine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00264	0.0265	CbGeAlD
Trimipramine—HTR2A—locus ceruleus—Parkinson's disease	0.0023	0.0231	CbGeAlD
Trimipramine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00225	0.0226	CbGeAlD
Trimipramine—HTR1D—telencephalic ventricle—Parkinson's disease	0.00219	0.0221	CbGeAlD
Trimipramine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00217	0.0218	CbGeAlD
Trimipramine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00203	0.0204	CbGeAlD
Trimipramine—HTR2A—cerebellar cortex—Parkinson's disease	0.00187	0.0188	CbGeAlD
Trimipramine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00183	0.0184	CbGeAlD
Trimipramine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00182	0.0183	CbGeAlD
Trimipramine—HTR3A—nerve—Parkinson's disease	0.0017	0.0171	CbGeAlD
Trimipramine—DRD2—telencephalic ventricle—Parkinson's disease	0.00165	0.0166	CbGeAlD
Trimipramine—SLC6A3—nerve—Parkinson's disease	0.00142	0.0142	CbGeAlD
Trimipramine—HTR2A—pons—Parkinson's disease	0.00132	0.0133	CbGeAlD
Trimipramine—HTR2A—autonomic nervous system—Parkinson's disease	0.00122	0.0123	CbGeAlD
Trimipramine—SLC6A2—nerve—Parkinson's disease	0.00114	0.0115	CbGeAlD
Trimipramine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00109	0.011	CbGeAlD
Trimipramine—SLC6A3—hindbrain—Parkinson's disease	0.00106	0.0107	CbGeAlD
Trimipramine—DRD2—nerve—Parkinson's disease	0.00104	0.0105	CbGeAlD
Trimipramine—ADRA2A—peripheral nervous system—Parkinson's disease	0.00104	0.0104	CbGeAlD
Trimipramine—SLC6A4—hindbrain—Parkinson's disease	0.000973	0.00977	CbGeAlD
Trimipramine—HTR2A—peripheral nervous system—Parkinson's disease	0.000881	0.00886	CbGeAlD
Trimipramine—HTR1A—hindbrain—Parkinson's disease	0.000864	0.00868	CbGeAlD
Trimipramine—ADRA1A—hindbrain—Parkinson's disease	0.000796	0.008	CbGeAlD
Trimipramine—DRD2—hindbrain—Parkinson's disease	0.00078	0.00784	CbGeAlD
Trimipramine—HTR3A—brainstem—Parkinson's disease	0.000731	0.00735	CbGeAlD
Trimipramine—HTR3A—forebrain—Parkinson's disease	0.000706	0.00709	CbGeAlD
Trimipramine—HTR2A—nerve—Parkinson's disease	0.000687	0.0069	CbGeAlD
Trimipramine—SLC6A3—brainstem—Parkinson's disease	0.000608	0.00611	CbGeAlD
Trimipramine—HTR1D—brainstem—Parkinson's disease	0.000594	0.00597	CbGeAlD
Trimipramine—HTR2C—brainstem—Parkinson's disease	0.000588	0.00591	CbGeAlD
Trimipramine—SLC6A3—forebrain—Parkinson's disease	0.000587	0.0059	CbGeAlD
Trimipramine—HTR1D—forebrain—Parkinson's disease	0.000573	0.00576	CbGeAlD
Trimipramine—HTR2C—forebrain—Parkinson's disease	0.000568	0.0057	CbGeAlD
Trimipramine—SLC6A4—brainstem—Parkinson's disease	0.000557	0.0056	CbGeAlD
Trimipramine—SLC6A4—forebrain—Parkinson's disease	0.000538	0.00541	CbGeAlD
Trimipramine—HTR2A—hindbrain—Parkinson's disease	0.000515	0.00517	CbGeAlD
Trimipramine—HTR1A—brainstem—Parkinson's disease	0.000495	0.00497	CbGeAlD
Trimipramine—SLC6A2—brainstem—Parkinson's disease	0.000491	0.00493	CbGeAlD
Trimipramine—HTR1D—cardiovascular system—Parkinson's disease	0.000485	0.00487	CbGeAlD
Trimipramine—HTR1A—forebrain—Parkinson's disease	0.000478	0.0048	CbGeAlD
Trimipramine—SLC6A2—forebrain—Parkinson's disease	0.000474	0.00476	CbGeAlD
Trimipramine—CYP2D6—hindbrain—Parkinson's disease	0.000469	0.00471	CbGeAlD
Trimipramine—ADRA1A—brainstem—Parkinson's disease	0.000456	0.00458	CbGeAlD
Trimipramine—ADRA1B—head—Parkinson's disease	0.000449	0.00451	CbGeAlD
Trimipramine—DRD2—brainstem—Parkinson's disease	0.000447	0.00449	CbGeAlD
Trimipramine—ADRA1A—forebrain—Parkinson's disease	0.00044	0.00442	CbGeAlD
Trimipramine—DRD2—forebrain—Parkinson's disease	0.000432	0.00434	CbGeAlD
Trimipramine—ADRA1B—nervous system—Parkinson's disease	0.000425	0.00428	CbGeAlD
Trimipramine—HTR2C—medulla oblongata—Parkinson's disease	0.00041	0.00412	CbGeAlD
Trimipramine—ADRA1B—central nervous system—Parkinson's disease	0.00041	0.00412	CbGeAlD
Trimipramine—HTR3A—head—Parkinson's disease	0.000404	0.00406	CbGeAlD
Trimipramine—HTR1A—cardiovascular system—Parkinson's disease	0.000404	0.00406	CbGeAlD
Trimipramine—SLC6A3—midbrain—Parkinson's disease	0.000388	0.0039	CbGeAlD
Trimipramine—HTR3A—nervous system—Parkinson's disease	0.000383	0.00385	CbGeAlD
Trimipramine—HTR1D—midbrain—Parkinson's disease	0.000378	0.0038	CbGeAlD
Trimipramine—SLC6A3—spinal cord—Parkinson's disease	0.000378	0.0038	CbGeAlD
Trimipramine—HTR2C—midbrain—Parkinson's disease	0.000375	0.00377	CbGeAlD
Trimipramine—ADRA1A—cardiovascular system—Parkinson's disease	0.000372	0.00374	CbGeAlD
Trimipramine—HTR3A—central nervous system—Parkinson's disease	0.000369	0.00371	CbGeAlD
Trimipramine—HTR2C—spinal cord—Parkinson's disease	0.000366	0.00367	CbGeAlD
Trimipramine—SLC6A4—midbrain—Parkinson's disease	0.000355	0.00357	CbGeAlD
Trimipramine—SLC6A4—spinal cord—Parkinson's disease	0.000347	0.00348	CbGeAlD
Trimipramine—SLC6A2—medulla oblongata—Parkinson's disease	0.000342	0.00344	CbGeAlD
Trimipramine—HRH1—forebrain—Parkinson's disease	0.000341	0.00343	CbGeAlD
Trimipramine—SLC6A3—head—Parkinson's disease	0.000336	0.00338	CbGeAlD
Trimipramine—ADRA2A—forebrain—Parkinson's disease	0.000335	0.00336	CbGeAlD
Trimipramine—HTR1D—head—Parkinson's disease	0.000328	0.0033	CbGeAlD
Trimipramine—ADRA1B—brain—Parkinson's disease	0.000325	0.00327	CbGeAlD
Trimipramine—HTR2C—head—Parkinson's disease	0.000325	0.00327	CbGeAlD
Trimipramine—HTR2A—embryo—Parkinson's disease	0.000322	0.00323	CbGeAlD
Trimipramine—SLC6A3—nervous system—Parkinson's disease	0.000319	0.0032	CbGeAlD
Trimipramine—HTR1A—midbrain—Parkinson's disease	0.000315	0.00317	CbGeAlD
Trimipramine—HTR1D—nervous system—Parkinson's disease	0.000311	0.00313	CbGeAlD
Trimipramine—HTR2C—nervous system—Parkinson's disease	0.000308	0.0031	CbGeAlD
Trimipramine—SLC6A4—head—Parkinson's disease	0.000308	0.0031	CbGeAlD
Trimipramine—HTR1A—spinal cord—Parkinson's disease	0.000308	0.00309	CbGeAlD
Trimipramine—SLC6A3—central nervous system—Parkinson's disease	0.000307	0.00308	CbGeAlD
Trimipramine—SLC6A3—cerebellum—Parkinson's disease	0.0003	0.00301	CbGeAlD
Trimipramine—HTR1D—central nervous system—Parkinson's disease	0.0003	0.00301	CbGeAlD
Trimipramine—HTR2C—central nervous system—Parkinson's disease	0.000297	0.00298	CbGeAlD
Trimipramine—HTR2A—brainstem—Parkinson's disease	0.000295	0.00296	CbGeAlD
Trimipramine—HTR3A—brain—Parkinson's disease	0.000293	0.00294	CbGeAlD
Trimipramine—CYP2C9—cardiovascular system—Parkinson's disease	0.000292	0.00294	CbGeAlD
Trimipramine—SLC6A4—nervous system—Parkinson's disease	0.000292	0.00293	CbGeAlD
Trimipramine—DRD2—midbrain—Parkinson's disease	0.000285	0.00286	CbGeAlD
Trimipramine—HTR2A—forebrain—Parkinson's disease	0.000285	0.00286	CbGeAlD
Trimipramine—Benzphetamine—SLC18A2—Parkinson's disease	0.000284	0.0406	CrCbGaD
Trimipramine—Benazepril—MTHFR—Parkinson's disease	0.000281	0.0403	CrCbGaD
Trimipramine—SLC6A4—central nervous system—Parkinson's disease	0.000281	0.00283	CbGeAlD
Trimipramine—HTR1A—head—Parkinson's disease	0.000274	0.00275	CbGeAlD
Trimipramine—SLC6A2—head—Parkinson's disease	0.000271	0.00273	CbGeAlD
Trimipramine—CYP2D6—brainstem—Parkinson's disease	0.000269	0.0027	CbGeAlD
Trimipramine—CYP2D6—forebrain—Parkinson's disease	0.000259	0.00261	CbGeAlD
Trimipramine—HTR1A—nervous system—Parkinson's disease	0.000259	0.00261	CbGeAlD
Trimipramine—SLC6A2—nervous system—Parkinson's disease	0.000257	0.00258	CbGeAlD
Trimipramine—ADRA1A—head—Parkinson's disease	0.000252	0.00253	CbGeAlD
Trimipramine—HTR1A—central nervous system—Parkinson's disease	0.00025	0.00251	CbGeAlD
Trimipramine—SLC6A2—central nervous system—Parkinson's disease	0.000248	0.00249	CbGeAlD
Trimipramine—DRD2—head—Parkinson's disease	0.000247	0.00248	CbGeAlD
Trimipramine—HTR1A—cerebellum—Parkinson's disease	0.000244	0.00245	CbGeAlD
Trimipramine—SLC6A3—brain—Parkinson's disease	0.000244	0.00245	CbGeAlD
Trimipramine—ADRA2A—medulla oblongata—Parkinson's disease	0.000242	0.00243	CbGeAlD
Trimipramine—HTR2A—cardiovascular system—Parkinson's disease	0.000241	0.00242	CbGeAlD
Trimipramine—ADRA1A—nervous system—Parkinson's disease	0.000239	0.0024	CbGeAlD
Trimipramine—HTR1D—brain—Parkinson's disease	0.000238	0.00239	CbGeAlD
Trimipramine—HTR2C—brain—Parkinson's disease	0.000235	0.00237	CbGeAlD
Trimipramine—DRD2—nervous system—Parkinson's disease	0.000234	0.00235	CbGeAlD
Trimipramine—ADRA1A—central nervous system—Parkinson's disease	0.00023	0.00231	CbGeAlD
Trimipramine—DRD2—central nervous system—Parkinson's disease	0.000226	0.00227	CbGeAlD
Trimipramine—Epinastine—HTR7—Parkinson's disease	0.000225	0.0322	CrCbGaD
Trimipramine—ADRA1A—cerebellum—Parkinson's disease	0.000225	0.00226	CbGeAlD
Trimipramine—SLC6A4—brain—Parkinson's disease	0.000223	0.00224	CbGeAlD
Trimipramine—ADRA2A—midbrain—Parkinson's disease	0.000221	0.00222	CbGeAlD
Trimipramine—DRD2—cerebellum—Parkinson's disease	0.00022	0.00222	CbGeAlD
Trimipramine—ADRA2A—spinal cord—Parkinson's disease	0.000216	0.00217	CbGeAlD
Trimipramine—ABCB1—embryo—Parkinson's disease	0.000211	0.00212	CbGeAlD
Trimipramine—HTR2A—medulla oblongata—Parkinson's disease	0.000206	0.00207	CbGeAlD
Trimipramine—HTR1A—brain—Parkinson's disease	0.000198	0.00199	CbGeAlD
Trimipramine—SLC6A2—brain—Parkinson's disease	0.000197	0.00197	CbGeAlD
Trimipramine—HRH1—head—Parkinson's disease	0.000195	0.00196	CbGeAlD
Trimipramine—ADRA2A—head—Parkinson's disease	0.000192	0.00193	CbGeAlD
Trimipramine—HTR2A—midbrain—Parkinson's disease	0.000188	0.00189	CbGeAlD
Trimipramine—ABCB1—forebrain—Parkinson's disease	0.000187	0.00187	CbGeAlD
Trimipramine—HRH1—nervous system—Parkinson's disease	0.000185	0.00186	CbGeAlD
Trimipramine—HTR2A—spinal cord—Parkinson's disease	0.000183	0.00184	CbGeAlD
Trimipramine—ADRA1A—brain—Parkinson's disease	0.000183	0.00184	CbGeAlD
Trimipramine—ADRA2A—nervous system—Parkinson's disease	0.000182	0.00183	CbGeAlD
Trimipramine—DRD2—brain—Parkinson's disease	0.000179	0.0018	CbGeAlD
Trimipramine—HRH1—central nervous system—Parkinson's disease	0.000178	0.00179	CbGeAlD
Trimipramine—ADRA2A—central nervous system—Parkinson's disease	0.000175	0.00176	CbGeAlD
Trimipramine—ADRA2A—cerebellum—Parkinson's disease	0.000171	0.00172	CbGeAlD
Trimipramine—HTR2A—head—Parkinson's disease	0.000163	0.00164	CbGeAlD
Trimipramine—ABCB1—cardiovascular system—Parkinson's disease	0.000158	0.00159	CbGeAlD
Trimipramine—HTR2A—nervous system—Parkinson's disease	0.000155	0.00155	CbGeAlD
Trimipramine—HTR2A—central nervous system—Parkinson's disease	0.000149	0.0015	CbGeAlD
Trimipramine—CYP2D6—head—Parkinson's disease	0.000148	0.00149	CbGeAlD
Trimipramine—Clomipramine—GSTP1—Parkinson's disease	0.000146	0.0208	CrCbGaD
Trimipramine—HTR2A—cerebellum—Parkinson's disease	0.000145	0.00146	CbGeAlD
Trimipramine—Acepromazine—DRD1—Parkinson's disease	0.000145	0.0207	CrCbGaD
Trimipramine—CYP3A4—nervous system—Parkinson's disease	0.000143	0.00144	CbGeAlD
Trimipramine—HRH1—brain—Parkinson's disease	0.000141	0.00142	CbGeAlD
Trimipramine—CYP2D6—nervous system—Parkinson's disease	0.000141	0.00141	CbGeAlD
Trimipramine—ADRA2A—brain—Parkinson's disease	0.000139	0.0014	CbGeAlD
Trimipramine—CYP3A4—central nervous system—Parkinson's disease	0.000138	0.00138	CbGeAlD
Trimipramine—CYP2D6—central nervous system—Parkinson's disease	0.000136	0.00136	CbGeAlD
Trimipramine—ABCB1—medulla oblongata—Parkinson's disease	0.000135	0.00135	CbGeAlD
Trimipramine—CYP2D6—cerebellum—Parkinson's disease	0.000132	0.00133	CbGeAlD
Trimipramine—Mianserin—HTR7—Parkinson's disease	0.00013	0.0187	CrCbGaD
Trimipramine—ABCB1—midbrain—Parkinson's disease	0.000123	0.00124	CbGeAlD
Trimipramine—Cyamemazine—HTR2A—Parkinson's disease	0.000123	0.0176	CrCbGaD
Trimipramine—Aprindine—CYP2D6—Parkinson's disease	0.000123	0.0176	CrCbGaD
Trimipramine—Mianserin—DRD3—Parkinson's disease	0.000123	0.0175	CrCbGaD
Trimipramine—Acepromazine—HTR1A—Parkinson's disease	0.00012	0.0172	CrCbGaD
Trimipramine—ABCB1—spinal cord—Parkinson's disease	0.00012	0.00121	CbGeAlD
Trimipramine—HTR2A—brain—Parkinson's disease	0.000118	0.00119	CbGeAlD
Trimipramine—Benzphetamine—SLC6A3—Parkinson's disease	0.000118	0.0168	CrCbGaD
Trimipramine—Propiomazine—DRD1—Parkinson's disease	0.000116	0.0166	CrCbGaD
Trimipramine—Cyclobenzaprine—HTR2A—Parkinson's disease	0.000114	0.0163	CrCbGaD
Trimipramine—Mianserin—SLC6A3—Parkinson's disease	0.000114	0.0163	CrCbGaD
Trimipramine—Epinastine—HTR2A—Parkinson's disease	0.000113	0.0162	CrCbGaD
Trimipramine—CYP2D6—brain—Parkinson's disease	0.000108	0.00108	CbGeAlD
Trimipramine—ABCB1—head—Parkinson's disease	0.000107	0.00107	CbGeAlD
Trimipramine—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.000104	0.0149	CrCbGaD
Trimipramine—Epinastine—CYP2D6—Parkinson's disease	0.000104	0.0148	CrCbGaD
Trimipramine—Acepromazine—DRD2—Parkinson's disease	0.000102	0.0146	CrCbGaD
Trimipramine—ABCB1—nervous system—Parkinson's disease	0.000101	0.00102	CbGeAlD
Trimipramine—Methotrimeprazine—DRD3—Parkinson's disease	0.000101	0.0144	CrCbGaD
Trimipramine—Mianserin—HTR1A—Parkinson's disease	9.99e-05	0.0143	CrCbGaD
Trimipramine—Methotrimeprazine—DRD1—Parkinson's disease	9.9e-05	0.0142	CrCbGaD
Trimipramine—Mequitazine—CYP2D6—Parkinson's disease	9.75e-05	0.014	CrCbGaD
Trimipramine—ABCB1—central nervous system—Parkinson's disease	9.75e-05	0.00098	CbGeAlD
Trimipramine—ABCB1—cerebellum—Parkinson's disease	9.53e-05	0.000958	CbGeAlD
Trimipramine—Nortriptyline—HTR1A—Parkinson's disease	8.93e-05	0.0128	CrCbGaD
Trimipramine—Promazine—DRD1—Parkinson's disease	8.58e-05	0.0123	CrCbGaD
Trimipramine—Mianserin—DRD2—Parkinson's disease	8.48e-05	0.0121	CrCbGaD
Trimipramine—Desipramine—SLC6A3—Parkinson's disease	8.39e-05	0.012	CrCbGaD
Trimipramine—Chlorpromazine—HTR7—Parkinson's disease	8.18e-05	0.0117	CrCbGaD
Trimipramine—Propiomazine—DRD2—Parkinson's disease	8.16e-05	0.0117	CrCbGaD
Trimipramine—Imipramine—HTR7—Parkinson's disease	8.14e-05	0.0116	CrCbGaD
Trimipramine—Amitriptyline—HTR7—Parkinson's disease	8.09e-05	0.0116	CrCbGaD
Trimipramine—Doxepin—HTR1A—Parkinson's disease	8.01e-05	0.0115	CrCbGaD
Trimipramine—Acepromazine—HTR2A—Parkinson's disease	7.89e-05	0.0113	CrCbGaD
Trimipramine—ABCB1—brain—Parkinson's disease	7.74e-05	0.000778	CbGeAlD
Trimipramine—Chlorpromazine—DRD3—Parkinson's disease	7.69e-05	0.011	CrCbGaD
Trimipramine—Amitriptyline—DRD3—Parkinson's disease	7.6e-05	0.0109	CrCbGaD
Trimipramine—Nortriptyline—DRD2—Parkinson's disease	7.58e-05	0.0108	CrCbGaD
Trimipramine—Chlorpromazine—DRD1—Parkinson's disease	7.55e-05	0.0108	CrCbGaD
Trimipramine—Epinastine—ABCB1—Parkinson's disease	7.4e-05	0.0106	CrCbGaD
Trimipramine—Desipramine—HTR1A—Parkinson's disease	7.35e-05	0.0105	CrCbGaD
Trimipramine—Nortriptyline—CYP2E1—Parkinson's disease	7.3e-05	0.0104	CrCbGaD
Trimipramine—Imipramine—SLC6A3—Parkinson's disease	7.12e-05	0.0102	CrCbGaD
Trimipramine—Dextropropoxyphene—CYP2D6—Parkinson's disease	7.05e-05	0.0101	CrCbGaD
Trimipramine—Methotrimeprazine—DRD2—Parkinson's disease	6.98e-05	0.00998	CrCbGaD
Trimipramine—Promethazine—DRD2—Parkinson's disease	6.87e-05	0.00983	CrCbGaD
Trimipramine—Doxepin—DRD2—Parkinson's disease	6.8e-05	0.00973	CrCbGaD
Trimipramine—Methotrimeprazine—CYP2E1—Parkinson's disease	6.72e-05	0.00961	CrCbGaD
Trimipramine—Mianserin—HTR2A—Parkinson's disease	6.56e-05	0.00938	CrCbGaD
Trimipramine—Orphenadrine—CYP2E1—Parkinson's disease	6.38e-05	0.00913	CrCbGaD
Trimipramine—Propiomazine—HTR2A—Parkinson's disease	6.31e-05	0.00902	CrCbGaD
Trimipramine—Chlorpromazine—HTR1A—Parkinson's disease	6.27e-05	0.00897	CrCbGaD
Trimipramine—Desipramine—DRD2—Parkinson's disease	6.24e-05	0.00893	CrCbGaD
Trimipramine—Imipramine—HTR1A—Parkinson's disease	6.24e-05	0.00892	CrCbGaD
Trimipramine—Amitriptyline—HTR1A—Parkinson's disease	6.2e-05	0.00887	CrCbGaD
Trimipramine—Promazine—DRD2—Parkinson's disease	6.05e-05	0.00865	CrCbGaD
Trimipramine—Desipramine—CYP2E1—Parkinson's disease	6.01e-05	0.0086	CrCbGaD
Trimipramine—Clomipramine—HTR2A—Parkinson's disease	6e-05	0.00858	CrCbGaD
Trimipramine—Mianserin—CYP2D6—Parkinson's disease	6e-05	0.00858	CrCbGaD
Trimipramine—Nortriptyline—HTR2A—Parkinson's disease	5.86e-05	0.00838	CrCbGaD
Trimipramine—Clomipramine—CYP2D6—Parkinson's disease	5.48e-05	0.00784	CrCbGaD
Trimipramine—Methotrimeprazine—HTR2A—Parkinson's disease	5.39e-05	0.00771	CrCbGaD
Trimipramine—Nortriptyline—CYP2D6—Parkinson's disease	5.36e-05	0.00766	CrCbGaD
Trimipramine—Chlorpromazine—DRD2—Parkinson's disease	5.32e-05	0.00761	CrCbGaD
Trimipramine—Promethazine—HTR2A—Parkinson's disease	5.31e-05	0.0076	CrCbGaD
Trimipramine—Imipramine—DRD2—Parkinson's disease	5.29e-05	0.00757	CrCbGaD
Trimipramine—Amitriptyline—DRD2—Parkinson's disease	5.26e-05	0.00753	CrCbGaD
Trimipramine—Doxepin—HTR2A—Parkinson's disease	5.26e-05	0.00752	CrCbGaD
Trimipramine—Chlorpromazine—CYP2E1—Parkinson's disease	5.12e-05	0.00733	CrCbGaD
Trimipramine—Imipramine—CYP2E1—Parkinson's disease	5.1e-05	0.00729	CrCbGaD
Trimipramine—Amitriptyline—CYP2E1—Parkinson's disease	5.06e-05	0.00724	CrCbGaD
Trimipramine—Diphenhydramine—CYP2D6—Parkinson's disease	4.95e-05	0.00709	CrCbGaD
Trimipramine—Methotrimeprazine—CYP2D6—Parkinson's disease	4.93e-05	0.00705	CrCbGaD
Trimipramine—Promethazine—CYP2D6—Parkinson's disease	4.86e-05	0.00695	CrCbGaD
Trimipramine—Desipramine—HTR2A—Parkinson's disease	4.82e-05	0.0069	CrCbGaD
Trimipramine—Doxepin—CYP2D6—Parkinson's disease	4.81e-05	0.00688	CrCbGaD
Trimipramine—Methadone—CYP2D6—Parkinson's disease	4.78e-05	0.00684	CrCbGaD
Trimipramine—Promazine—HTR2A—Parkinson's disease	4.67e-05	0.00668	CrCbGaD
Trimipramine—Carbamazepine—ABCB1—Parkinson's disease	4.65e-05	0.00665	CrCbGaD
Trimipramine—Desipramine—CYP2D6—Parkinson's disease	4.41e-05	0.00631	CrCbGaD
Trimipramine—Chlorpromazine—HTR2A—Parkinson's disease	4.11e-05	0.00588	CrCbGaD
Trimipramine—Imipramine—HTR2A—Parkinson's disease	4.09e-05	0.00585	CrCbGaD
Trimipramine—Amitriptyline—HTR2A—Parkinson's disease	4.07e-05	0.00582	CrCbGaD
Trimipramine—Clomipramine—ABCB1—Parkinson's disease	3.92e-05	0.0056	CrCbGaD
Trimipramine—Chlorpromazine—CYP2D6—Parkinson's disease	3.76e-05	0.00538	CrCbGaD
Trimipramine—Imipramine—CYP2D6—Parkinson's disease	3.74e-05	0.00535	CrCbGaD
Trimipramine—Amitriptyline—CYP2D6—Parkinson's disease	3.72e-05	0.00532	CrCbGaD
Trimipramine—Promethazine—ABCB1—Parkinson's disease	3.47e-05	0.00496	CrCbGaD
Trimipramine—Doxepin—ABCB1—Parkinson's disease	3.43e-05	0.00491	CrCbGaD
Trimipramine—Methadone—ABCB1—Parkinson's disease	3.42e-05	0.00489	CrCbGaD
Trimipramine—Desipramine—ABCB1—Parkinson's disease	3.15e-05	0.00451	CrCbGaD
Trimipramine—Chlorpromazine—ABCB1—Parkinson's disease	2.69e-05	0.00384	CrCbGaD
Trimipramine—Imipramine—ABCB1—Parkinson's disease	2.67e-05	0.00382	CrCbGaD
Trimipramine—Amitriptyline—ABCB1—Parkinson's disease	2.66e-05	0.0038	CrCbGaD
Trimipramine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	8.93e-06	6.4e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	8.91e-06	6.38e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	8.91e-06	6.38e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	8.91e-06	6.38e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—MAOB—Parkinson's disease	8.9e-06	6.37e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GBA—Parkinson's disease	8.87e-06	6.35e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—FBP1—Parkinson's disease	8.87e-06	6.35e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—DBH—Parkinson's disease	8.87e-06	6.35e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	8.86e-06	6.35e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	8.86e-06	6.35e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	8.8e-06	6.31e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NGF—Parkinson's disease	8.79e-06	6.29e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	8.79e-06	6.29e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	8.77e-06	6.28e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	8.77e-06	6.28e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	8.76e-06	6.27e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	8.74e-06	6.26e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.67e-06	6.21e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	8.65e-06	6.19e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—NQO1—Parkinson's disease	8.65e-06	6.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	8.6e-06	6.16e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—TH—Parkinson's disease	8.52e-06	6.1e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	8.51e-06	6.09e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	8.49e-06	6.08e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	8.48e-06	6.08e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	8.48e-06	6.08e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	8.47e-06	6.06e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	8.39e-06	6.01e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—MAOB—Parkinson's disease	8.38e-06	6e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	8.37e-06	5.99e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	8.33e-06	5.97e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	8.32e-06	5.96e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—MAOB—Parkinson's disease	8.31e-06	5.95e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	8.3e-06	5.95e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	8.28e-06	5.93e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CYCS—Parkinson's disease	8.18e-06	5.86e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	8.15e-06	5.84e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	8.08e-06	5.78e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	7.99e-06	5.73e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	7.95e-06	5.69e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	7.93e-06	5.68e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.91e-06	5.66e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	7.82e-06	5.6e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	7.78e-06	5.57e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—APOE—Parkinson's disease	7.78e-06	5.57e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	7.74e-06	5.55e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	7.73e-06	5.54e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	7.7e-06	5.51e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	7.7e-06	5.51e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	7.68e-06	5.5e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	7.68e-06	5.5e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	7.54e-06	5.4e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	7.54e-06	5.4e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	7.48e-06	5.36e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	7.47e-06	5.35e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	7.43e-06	5.32e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	7.39e-06	5.29e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—COMT—Parkinson's disease	7.25e-06	5.19e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	7.23e-06	5.18e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	7.22e-06	5.17e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	7.21e-06	5.16e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—MAOA—Parkinson's disease	7.19e-06	5.15e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	7.18e-06	5.14e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	7.13e-06	5.11e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	7.11e-06	5.09e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	7.11e-06	5.09e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	7.1e-06	5.08e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	7e-06	5.01e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	7e-06	5.01e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	6.87e-06	4.92e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	6.83e-06	4.89e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	6.79e-06	4.86e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	6.79e-06	4.86e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	6.77e-06	4.85e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CTGF—Parkinson's disease	6.65e-06	4.76e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—INS—Parkinson's disease	6.64e-06	4.76e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	6.63e-06	4.75e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	6.61e-06	4.73e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	6.55e-06	4.69e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	6.55e-06	4.69e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	6.52e-06	4.67e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—DDC—Parkinson's disease	6.51e-06	4.66e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CTGF—Parkinson's disease	6.49e-06	4.65e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	6.46e-06	4.63e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	6.45e-06	4.62e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	6.44e-06	4.61e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GPX1—Parkinson's disease	6.35e-06	4.55e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	6.34e-06	4.54e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	6.32e-06	4.52e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	6.26e-06	4.48e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	6.24e-06	4.47e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	6.24e-06	4.47e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	6.24e-06	4.47e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	6.22e-06	4.46e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	6.21e-06	4.45e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	6.2e-06	4.44e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	6.18e-06	4.42e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	6.16e-06	4.41e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.15e-06	4.4e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	6.15e-06	4.4e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—NQO1—Parkinson's disease	6.13e-06	4.39e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CTGF—Parkinson's disease	6.12e-06	4.38e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	6.11e-06	4.37e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CTGF—Parkinson's disease	6.06e-06	4.34e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	6.05e-06	4.33e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—TH—Parkinson's disease	6.04e-06	4.32e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	6.03e-06	4.32e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	6.01e-06	4.3e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—NQO1—Parkinson's disease	5.98e-06	4.28e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	5.94e-06	4.26e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—TH—Parkinson's disease	5.89e-06	4.22e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	5.87e-06	4.2e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	5.86e-06	4.19e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	5.8e-06	4.15e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYCS—Parkinson's disease	5.8e-06	4.15e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	5.77e-06	4.13e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NGF—Parkinson's disease	5.75e-06	4.12e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.7e-06	4.08e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	5.67e-06	4.06e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.66e-06	4.06e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYCS—Parkinson's disease	5.66e-06	4.05e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NGF—Parkinson's disease	5.65e-06	4.05e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	5.65e-06	4.05e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.63e-06	4.04e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	5.61e-06	4.01e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NQO1—Parkinson's disease	5.59e-06	4e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—TH—Parkinson's disease	5.55e-06	3.98e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	5.54e-06	3.97e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.54e-06	3.96e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	5.52e-06	3.96e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—TH—Parkinson's disease	5.5e-06	3.94e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MAOB—Parkinson's disease	5.48e-06	3.93e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	5.48e-06	3.92e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—APOE—Parkinson's disease	5.45e-06	3.9e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	5.38e-06	3.85e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYCS—Parkinson's disease	5.33e-06	3.82e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYCS—Parkinson's disease	5.29e-06	3.79e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	5.28e-06	3.78e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	5.15e-06	3.69e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—INS—Parkinson's disease	5.13e-06	3.68e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—COMT—Parkinson's disease	5.13e-06	3.68e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	5.11e-06	3.66e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—MAOA—Parkinson's disease	5.1e-06	3.65e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—APOE—Parkinson's disease	5.09e-06	3.65e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	5.04e-06	3.61e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	5.01e-06	3.59e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—COMT—Parkinson's disease	5.01e-06	3.59e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—APOE—Parkinson's disease	5e-06	3.58e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSTP1—Parkinson's disease	4.99e-06	3.57e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—MAOA—Parkinson's disease	4.98e-06	3.56e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—INS—Parkinson's disease	4.96e-06	3.55e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	4.95e-06	3.54e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—INS—Parkinson's disease	4.93e-06	3.53e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—HMOX1—Parkinson's disease	4.92e-06	3.52e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	4.91e-06	3.52e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	4.91e-06	3.51e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	4.9e-06	3.51e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	4.84e-06	3.46e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—COMT—Parkinson's disease	4.72e-06	3.38e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	4.72e-06	3.38e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.7e-06	3.37e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	4.7e-06	3.36e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.69e-06	3.36e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—COMT—Parkinson's disease	4.68e-06	3.35e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	4.66e-06	3.34e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—INS—Parkinson's disease	4.66e-06	3.34e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—MAOA—Parkinson's disease	4.65e-06	3.33e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.63e-06	3.32e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	4.59e-06	3.29e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSTM1—Parkinson's disease	4.58e-06	3.28e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	4.56e-06	3.27e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	4.55e-06	3.26e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GPX1—Parkinson's disease	4.5e-06	3.22e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4.45e-06	3.19e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	4.41e-06	3.16e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GPX1—Parkinson's disease	4.39e-06	3.14e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—INS—Parkinson's disease	4.35e-06	3.12e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	4.32e-06	3.09e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—INS—Parkinson's disease	4.28e-06	3.07e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	4.28e-06	3.07e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—INS—Parkinson's disease	4.27e-06	3.06e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	4.19e-06	3e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	4.15e-06	2.97e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GPX1—Parkinson's disease	4.14e-06	2.96e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GPX1—Parkinson's disease	4.1e-06	2.94e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.07e-06	2.92e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—MTHFR—Parkinson's disease	4.05e-06	2.9e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CTGF—Parkinson's disease	4e-06	2.86e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	3.89e-06	2.79e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—APOE—Parkinson's disease	3.86e-06	2.77e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	3.82e-06	2.74e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.82e-06	2.73e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	3.8e-06	2.72e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	3.78e-06	2.71e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APOE—Parkinson's disease	3.77e-06	2.7e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.73e-06	2.67e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.69e-06	2.64e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.68e-06	2.64e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.67e-06	2.63e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.67e-06	2.63e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.65e-06	2.61e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TH—Parkinson's disease	3.63e-06	2.6e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOE—Parkinson's disease	3.55e-06	2.54e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOE—Parkinson's disease	3.52e-06	2.52e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	3.51e-06	2.52e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	3.51e-06	2.52e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	3.49e-06	2.5e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.49e-06	2.5e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	3.39e-06	2.43e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.37e-06	2.42e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—INS—Parkinson's disease	3.3e-06	2.36e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.24e-06	2.32e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	3.23e-06	2.31e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—INS—Parkinson's disease	3.22e-06	2.31e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.22e-06	2.3e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.19e-06	2.28e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	3.18e-06	2.28e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	3.17e-06	2.27e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	3.16e-06	2.26e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	3.12e-06	2.24e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	3.1e-06	2.22e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—COMT—Parkinson's disease	3.09e-06	2.21e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.07e-06	2.2e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.07e-06	2.2e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—INS—Parkinson's disease	3.04e-06	2.17e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.03e-06	2.17e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—INS—Parkinson's disease	3.01e-06	2.15e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.98e-06	2.13e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.93e-06	2.1e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.92e-06	2.09e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.91e-06	2.08e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.9e-06	2.08e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.9e-06	2.08e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.88e-06	2.06e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.87e-06	2.05e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.82e-06	2.02e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.7e-06	1.94e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.67e-06	1.91e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.5e-06	1.79e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOE—Parkinson's disease	2.32e-06	1.66e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	2.24e-06	1.61e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.17e-06	1.55e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.15e-06	1.54e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	2.06e-06	1.48e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—INS—Parkinson's disease	1.98e-06	1.42e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.9e-06	1.36e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.87e-06	1.34e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.87e-06	1.34e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.83e-06	1.31e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.7e-06	1.22e-05	CbGpPWpGaD
